VRDN
Viridian Therapeutics, Inc.
$30.48−0.77 (−2.46%)Close Nov 12, 2026
Jun 18, 2014 – Nov 12, 2026, Dividends reinvested
- Final balance
- $149
- CAGR
- −28.76%
- Max drawdown
- −99.73%
- Sharpe ratio
- 0.21
Loading the growth chart…
Growth of $10,000
Trailing returns (%)
VRDN's average annual return was −9.36% over the last 10 years, through Nov 12, 2026. $10,000 in VRDN on Nov 11, 2016 fell to $3,742 by Nov 12, 2026, with dividends reinvested.
Total
- 1M
- +66.56%
- 3M
- +33.22%
- 6M
- +80.78%
- YTD
- −2.06%
- 1Y
- +5.32%
Per year
- 3Y
- +30.36%
- 5Y
- +9.70%
- 10Y
- −9.36%
- Since 2014
- −28.76%
Annual returns
2014 from Jun 18 · 2026 through Nov 12
VRDN returns by year
| Year | Return |
|---|---|
| 2026 through Nov 12 | −2.06% |
| 2025 | +62.34% |
| 2024 | −11.98% |
| 2023 | −25.44% |
| 2022 | +47.75% |
| 2021 | +20.18% |
| 2020 | +128.47% |
| 2019 | −84.16% |
| 2018 | −70.95% |
| 2017 | +108.18% |
Metrics
Since 2014| Volatility | 132.01% |
|---|---|
| Sortino ratio | 0.46 |
| Calmar ratio | −0.29 |
| Best year, 2020 | +128.47% |
| Worst year, 2019 | −84.16% |
| Positive years | 5 of 11 |
| Longest drawdown | 12.4 years |
Worst drawdowns
Since 2014| Decline | Peak | Bottom | Recovered | Length |
|---|---|---|---|---|
| −99.7% | Jun 2014 | Mar 2020 | Not yet | 12.4 years so far |